-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Skinovation Pharmaceutical Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Skinovation Pharmaceutical Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.89K, a 68.7% decline year-over-year.
- Skinovation Pharmaceutical Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$22.3K, a 55.5% decline year-over-year.
- Skinovation Pharmaceutical Inc annual Operating Income (Loss) for 2023 was -$14.9K, a 6.19% decline from 2022.
- Skinovation Pharmaceutical Inc annual Operating Income (Loss) for 2022 was -$14.1K, a 1.66% decline from 2021.
- Skinovation Pharmaceutical Inc annual Operating Income (Loss) for 2021 was -$13.8K, a 2.26% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)